Post-earnings recap
Reported
Thu, Oct 26, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Lemaitre Vascular reported better-than-expected earnings per share, which indicates some operational strength. However, the stock fell by 2% on the day, likely due to a lack of revenue details and no guidance for future performance. Investors may be cautious as the company navigates a competitive market landscape.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.25 | N/A | +19.05% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their product pipeline and market position. However, they acknowledged challenges in the broader retail environment.
Management highlighted strong performance in key product areas.
They noted ongoing investments in R&D to drive future growth.